SERCA2a gene therapy for heart failure: Ready for primetime?

Molecular Therapy

Volumn 16, Issue 6, 2008, Pages 1002-1004

  Periasamy, Muthu ^a   Kalyanasundaram, Anuradha ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; MYDICAR; PARVOVIRUS VECTOR; PHOSPHOLAMBAN; PLACEBO; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; SODIUM CALCIUM EXCHANGE PROTEIN;

ARTERY INTIMA PROLIFERATION; CALCIUM TRANSPORT; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; NOTE; VIRAL GENE DELIVERY SYSTEM;

EID: 44349091648     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.89     Document Type: Note

References (21)

1. Cohn, JN (1997). Overview of the treatment of heart failure. Am J Cardiol 80: 2L-6L.
2. Ly, H, Kawase, Y, Yoneyama, R and Hajjar, RJ (2007). Gene therapy in the treatment of heart failure. Physiology (Bethesda) 22: 81-96.
3. del Monte, F, Hajjar, RJ and Harding, SE (2001). Over-whelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res 88: E66-E67.
4. Lebeche, D, Kaprelian, R, del Monte, F, Tomaselli, G, Gwathmey, JK, Schwartz, A et al. (2004). In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 110: 3435-3443.
5. Hajjar, RJ, Schmidt, U, Matsui, T, Guerrero, JL, Lee, KH, Gwathmey, JK et al. (1998). Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 95: 5251-5256.
6. Hajjar, RJ and Samulski, RJ (2006). Heart failure: A silver bullet to treat heart failure. Gene Ther 13: 997.
7. del Monte, F, Kizana, E, Tabchy, A and Hajjar, RJ (2004). Targeted gene transfer in heart failure: Implications for novel gene identification. Curr Opin Mol Ther 6: 381-394.
8. del Monte, F, Lebeche, D, Guerrero, JL, Tsuji, T, Doye, AA, Gwathmey, JK et al. (2004). Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci USA 101: 5622-5627.
9. Niwano, K, Arai, M, Koitabashi, N, Watanabe, A, Ikeda, Y, Miyoshi, H et al. (2008). Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther 16: 1026-1032.
10. Arai, M, Alpert, NR, MacLennan, DH, Barton, P and Periasamy, M (1993). Alterations in sarcoplasmic reticulum gene expression in human heart failure: A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469.
11. 2+ content in isolated failing and nonfailing human myocardium. Circ Res 85: 38-46.
12. Hasenfuss, G (1998). Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37, 279-289.
13. Hasenfuss, G, Holubarsch, C, Hermann, HP, Astheimer, K, Pieske, B and Just, H (1994). Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 15: 164-170.
14. Hasenfuss, G, Reinecke, H, Studer, R, Meyer, M, Pieske, B, Holtz, J et al. (1994). Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442.
15. Hasenfuss, G, Reinecke, H, Studer, R, Pieske, B, Meyer, M, Drexler, H et al. (1996). Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol 91(Suppl 2): 17-22.
16. 2+-ATPase. Circ Res 83: 889-897.
17. del Monte, F, Harding, SE, Schmidt, U, Matsui, T, Kang, ZB, Dec, GW et al. (1999). Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100: 2308-2311.
18. Beeri, R, Guerrero, JL, Supple, G, Sullivan, S, Levine, RA and Hajjar, RJ (2002). New efficient catheter-based system for myocardial gene delivery. Circulation 106: 1756-1759.
19. Miyamoto, MI, del Monte, F, Schmidt, U, DiSalvo, TS, Kang, ZB, Matsui, T et al. (2000). Adenoviral gene transfer of SERCA2a improves left ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97: 793-798.
20. del Monte, F, Williams, E, Lebeche, D, Schmidt, U, Rosenzweig, A, Gwathmey, JK et al. (2001). Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 104: 1424-1429.
21. Dishart, KL, Denby, L, George, SJ, Nicklin, SA, Yendluri, S, Tuerk, MJ et al. (2003). Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: Implications for Gene Therapy. J Mol Cell Cardiol 35: 739-748.